Dr. Leonid Kleynberg, MD

Dr. Kleynberg practices at Steven a Burres MD - 6221 Wilshire Blvd in Los Angeles, California.

Dr. Kleynberg's NPI, 1891750212, was assigned on April 19, 2006. Dr. Kleynberg holds California license A76900.

Dr. Kleynberg's primary practice is Steven a Burres MD - 6221 Wilshire Blvd, at 6221 W Wilshire Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (323) 937-1673.

Dr. Kleynberg's primary practice is Steven a Burres MD - 6221 Wilshire Blvd in Los Angeles, California. Dr. Kleynberg is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Kleynberg Medical Clinic. Dmand AI also links Dr. Kleynberg to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kleynberg practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kleynberg's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kleynberg is licensed in California.

CMS data shows 123,753 Medicare services from Dr. Kleynberg across 34 procedure codes in 2024, for 282 Medicare patients. Medicare paid $1,949,756 for them. Every service was in an office.

CMS counts 282 Medicare patients who saw Dr. Kleynberg in 2024. The largest group is 75 to 84, with 119 patients. 75% of them have arthritis, and 75% have diabetes. 87% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kleynberg's median patient age at 63, with 60% women.

In 2024, Dr. Kleynberg wrote 286 Medicare Part D claims for 60 patients. 73% of them were for generic drugs. CMS names the drug for 85 of them, across 6 drugs with 11 or more claims each, at $371,414 in total drug cost. In 2023, CMS named 65 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kleynberg for performance year 2024, reported individually. Dr. Kleynberg accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kleynberg as offering telehealth.

Dmand AI links 1 paper to Dr. Kleynberg in 2010. Dr. Kleynberg's most frequent co-authors are Roman Leonid Kleynberg, MD and Vera M. Kleynberg, MD.

CMS Open Payments shows 903 general payments to Dr. Kleynberg from 85 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Bristol-Myers Squibb Company paid the most, $2,127.